Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Anaxagoras who wrote (3863)	5/4/1998 8:11:00 AM
From: Linda Kaplan	Respond to of 7041

Some think that if Vasomax were approved, it would have an advantage over Viagra because it purportedly works in 15 minutes rather than an hour or two. Viagra is working on a version that works in five minutes, according to CNBC news this morning. Here's a WSJ article about this development: Headline: Pfizer (NYSE:PFE) seeks faster form of Viagra-WSJ ====================================================================== NEW YORK, May 4 (Reuters) - Pfizer Inc. has signed a deal with R.P. Scherer Corp. (NYSE:SHR) to help develop a faster-acting version of Viagra, the hot-selling new anti-impotence drug, the Wall Street Journal reported Monday. Currently, men must take the pill one hour before they can have sex. But under the pact with Troy, Mich.-based Scherer, the drug may take new form to speed up its effects, the Journal reported in its electronic edition. Pfizer is performing biochemical research on Scherer's Zydis delivery system and may proceed to clinical trials if it can, the paper said. Zydis is a wafer-thin delivery agent that may allow patients to take Viagra only a few minutes before sex, the paper said. Pfizer officials told the paper that any new form for Viagra is still years away. Copyright 1998, Reuters News Service

To: Anaxagoras who wrote (3863)	5/4/1998 9:25:00 AM
From: Linda Kaplan	Respond to of 7041

I noticed that when it came to upcoming news, some of our "longs" hinted about it and knew about it, but never posted it for all of us. It was nice of me to post the poster here, while any of them could have posted it sooner. Now, I'll give them something to think about. The NEJM will have a pice in a week or so that should raise the bar in terms of standards for quality studies on ED drugs. Considering the quality we've seen on Zonagen's studies, I expect this might lead to some additional hurdles for Vasomax. Linda

To: Anaxagoras who wrote (3863)	5/4/1998 11:04:00 AM
From: Dauntless	Respond to of 7041

Anaxagoras - The release, or not, of another "report by Asensio ... will be a good indicator of his position - IMHO. Zonagen was mentioned this morning on Don Imus' national radio show. Imus is an irreverent radio jock with one of the largest audiences around - I think he claims about 20 million listeners. Mentioned Zonagen as a small company with a pill that "does the same thing as Viagra" but that "the stock was only around $30/share". He has been having lots of fun with Viagra since its introduction - songs, comedy skits, etc. They really don't know much about Viagra, ED, etc - but it's great to get the name mentioned. Of course, I suppose he's now part of the scam?